Live Breaking News & Updates on குடும்பம் தடுப்பூசி|Page 2

Stay updated with breaking news from குடும்பம் தடுப்பூசி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MyEG to launch at-home, saliva-based Covid-19 test in the Philippines


Picture for representational purposes only. – AFPPIX
PETALING JAYA: MYEG Services Bhd (MyEG) plans to introduce this month an at-home, saliva-based Covid-19 testing service in the Philippines, a safe and non-invasive test aimed at helping the country’s fight against the ongoing pandemic by accelerating and enhancing screening.
As the exclusive distributor of the kit, MyEG will be making the service – the first of its kind in the Philippine market – available through its joint venture I-Pay MYEG Philippines Inc, in collaboration with IP Biotech, Inc (a licensed importer of vaccines and medical devices in the Philippines), and Family Vaccine and Specialty Clinics Inc, one of the largest chains of vaccination clinics in the country. ....

United Kingdom , Malaysia General , South Africa , Ip Biotech Inc , Services Bhd My , Drug Administration , Specialty Clinics Inc , Philippines Inc , Family Vaccine , ஒன்றுபட்டது கிஂக்டம் , மலேசியா ஜநரல் , இப் பயோடெக் இன்க் , சேவைகள் ப்ட் என் , சிறப்பு கிளினிக்குகள் இன்க் , பிலிப்பைன்ஸ் இன்க் , குடும்பம் தடுப்பூசி ,

MYEG introduces at-home, saliva-based Covid-19 test in Philippines


has announced an at-home, saliva-based Covid-19 testing service for the Philippines.
The method is safe and non-invasive, and is aimed at helping the country s fight against the pandemic by accelerating and enhancing screening, it said in a statement.
The diagnostic kit enables the on-site collection of saliva samples at home or at the workplace by licensed medical professionals.
Samples are then sent to partner laboratories for processing, with test results delivered within one to two working days.
The kit has received the approval of the Food and Drug Administration in the Philippines, as well as by authorities in Singapore and Indonesia. ....

Kuala Lumpur , United Kingdom , South Africa , My Eg Services Bhd , Ip Biotech Inc , Drug Administration , Specialty Clinics Inc , Philippines Inc , Family Vaccine , Specialty Clinics , குவாலா லம்பூர் , ஒன்றுபட்டது கிஂக்டம் , என் எ.கா. சேவைகள் ப்ட் , இப் பயோடெக் இன்க் , சிறப்பு கிளினிக்குகள் இன்க் , பிலிப்பைன்ஸ் இன்க் , குடும்பம் தடுப்பூசி , சிறப்பு கிளினிக்குகள் ,

Indian group applies for emergency use authorization of COVAXIN in PH


Indian group applies for emergency use authorization of COVAXIN in PH
enablePagination: false
(FILE PHOTO)
Metro Manila (CNN Philippines, January 21) An Indian group has applied for emergency use authorization for COVAXIN, making it the fourth brand of COVID-19 vaccine to seek approval for distribution in the country.
Ambica International Corporation and Family Vaccine (FVSC) and specialty clinics (through IP Biotech) has filed for emergency use authorization (EUA) for COVAXIN, India s indigenous vaccine in the Philippines, a statement released on Thursday said.
The EUA was filed with the Food and Drug Administration on Wednesday, it also said.
According to the statement, FVSC and Ambica International Corporation consortium signed an agreement with Bharat Biotech International Ltd., the developer of the vaccine, to distribute COVAXIN should it meet FDA standards. ....

United Kingdom , Metro Manila , Philippines General , Drug Administration On , Sinovac Biotech , Gamaleya Research Institute , Bharat Biotech International Ltd , Ambica International Corporation , International Corporation , Family Vaccine , Drug Administration , Bharat Biotech , ஒன்றுபட்டது கிஂக்டம் , மெட்ரோ மணிலா , பிலிப்பைன்ஸ் ஜநரல் , பாரத் பயோடெக் சர்வதேச லிமிடெட் , அம்பிகா சர்வதேச நிறுவனம் , சர்வதேச நிறுவனம் , குடும்பம் தடுப்பூசி , பாரத் பயோடெக் ,

PH emergency use approval sought for Indian firm's COVID vaccine